drugset / Trial / NCT03555942
Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa
Non-randomizedSequentialOpen-labelTreatment
Summary
To evaluate the effect of random-start of ovarian stimulation initiated in the early follicular or luteal phase on the pharmacokinetics and follicular dynamics and embryo euploidy rates in oocyte donors treated with identical ovarian stimulation protocols with corifollitropin alfa and GnRH antagonist pituitary downregulation
Timeline
- Start
- 2018-05-08
- Primary completion
- 2021-11-30
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Corifollitropin alfa | Protein / enzyme biologic | 150 ug | Subcutaneous |